Showing 101 - 120 results of 377 for search 'free agent', query time: 0.05s Refine Results
  1. 101
  2. 102

    Two New 1,1,3,3-Tetramethylguanidinium Halochromates (C5H14N3CrO3X) (X: Cl, F): Efficient Reagents for Oxidation of Organic Substrates under Solvent-Free Conditions and Microwave I... by Kıvılcım Şendıl, H. Beytiye Özgün, Ebru Üstün

    Published 2016-01-01
    “…Two new mild oxidizing agents 1,1,3,3-tetramethylguanidinium fluorochromate (TMGFC) and 1,1,3,3-tetramethylguanidinium chlorochromate (TMGCC) were prepared in high yields by reacting tetramethylguanidine with CrO3 and related acid. …”
    Get full text
    Article
  3. 103

    PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis by Michela Roberto, Mattia Alberto Di Civita, Daniele Marinelli, Andrea Torchia, Nertila Cara, Giulia Maltese, Iolanda Speranza, Daniele Santini

    Published 2025-01-01
    “…Abstract Background We present a systematic review and meta‐analysis of randomized clinical trials (RCTs) with PARPi either as monotherapy or in combination with an androgen receptor‐targeted agent (ARTA) in first‐ and second‐line settings. …”
    Get full text
    Article
  4. 104
  5. 105

    Application of ZnO Semiconductor Nanomaterial Ink in Packaging and Printing Design by Changjian Guo

    Published 2022-01-01
    “…The method uses zinc acetate dihydrate as raw material, ethylenediamine as a complexing agent, absolute ethanol as a solvent, and ethyl cellulose as an auxiliary agent to prepare particle-free ZnO functional ink. …”
    Get full text
    Article
  6. 106
  7. 107

    A Study on Deep Learning Based Parking Lot Allotment to the Vehicles by Aziza Algarni

    Published 2022-03-01
    “…Parking a vehicle in dense traffic environments often leads to excessive driving time in search of free space, which leads to congestion and environmental pollution. …”
    Get full text
    Article
  8. 108

    Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia by Brandi Anders, Lauren Veltri, Abraham S. Kanate, Alexandra Shillingburg, Nilay Shah, Michael Craig, Aaron Cumpston

    Published 2017-01-01
    “…Relapsed/refractory acute myeloid leukemia (RR-AML) is associated with poor prognosis and long-term disease-free survival requires allogeneic hematopoietic cell transplantation (allo-HCT). …”
    Get full text
    Article
  9. 109
  10. 110

    Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats by Gu Fugen, Ning Jia, Fan Huimin, Wu Chunzhi, Wang Yi

    Published 2018-06-01
    “…Main pharmacokinetic parameters such as tmax, cmax were significantly different (p < 0.01) between the simvastatin complex and free drug. Bioavailability of the simvastatin complex relative to free drug was up to 167.0 %.…”
    Get full text
    Article
  11. 111

    In vivo anti-aging properties on fat diet-induced high fat Drosophila melanogaster of n-butanol extract from Paecilomyces hepiali by Akang Dan, Yushi Chen, Yongqi Tian, Shaoyun Wang

    Published 2023-07-01
    “…The purpose of this study was to explore the potential of the development and application of Paecilomyces hepiali, a fungus with edible and medicinal value, as a foodborne antioxidant and anti-aging agent. Its n-butanol extract (PHE) from rice cultures was selected for anti-aging experiment because of significant free radical scavenging activity in vitro. …”
    Get full text
    Article
  12. 112

    Galectin-1-Dependent Mitochondria Apoptosis Plays an Essential Role in the Potential Protein Targets of DBDCT-Induced Hepatotoxicity as Revealed by Quantitative Proteomic Analyses by Jiayu Song, Yuan Ren, Lihua Liu, Yixin Wang, Chuandao Shi, Xiaoqing Ji, Yunlan Li, Qingshan Li

    Published 2022-01-01
    “…Di-n-butyl-di-(4-chlorobenzohydroxamato) tin(IV) (DBDCT), a new patent agent, exhibited strong antitumor activity. In some cases, its activity was close to or even higher than cisplatin, a first-line clinical metallic agent. …”
    Get full text
    Article
  13. 113

    Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases by Alireza Ebrahimi, Amirhossein Kamyab, Sahar Hosseini, Sedigheh Ebrahimi, Soheil Ashkani-Esfahani

    Published 2023-01-01
    “…This study reviews the literature to highlight this agent’s potential therapeutic effects in the mentioned neurological disorders.…”
    Get full text
    Article
  14. 114

    Patient Care and Support Measures Overcome Reluctance to Initiate New Regimen Containing Enfuvirtide by Benoit Trottier

    Published 2007-01-01
    “…Because the introduction of a new drug class can substantially enhance the efficacy of an antiretroviral regimen, supporting the patient in the introduction of enfuvirtide, a safe and efficacious agent in a new class, offers therapeutic benefits. …”
    Get full text
    Article
  15. 115

    Absential Suspension: Malebranche and Locke on Human Freedom by Julie Walsh

    Published 2019-09-01
    “…This paper treats a heretofore-unnoticed concept in the history of the philosophical discussion of human freedom, a kind of freedom that is not defined solely in terms of the causal power of the agent. Instead, the exercise of freedom essentially involves the non-occurrence of something.That being free involves the non-occurrence, that is, the absence, of an act may seem counterintuitive. …”
    Get full text
    Article
  16. 116

    Problem of contagious bovine pleuropneumonia by A. V. Piskunov, A. V. Kononov, A. V. Mischenko

    Published 2018-04-01
    “…Today, there is a huge risk of the agent introduction with animals and raw material exported from affected endemic areas of Africa to the areas free from contagious bovine pleuropneumonia (including Eurasia).…”
    Get full text
    Article
  17. 117

    Synthesis and Antioxidative Activity of Piperine Derivatives Containing Phenolic Hydroxyl by Bei Qin, Kuan Yang, Ruijun Cao

    Published 2020-01-01
    “…This study synthesized novel piperine derivatives for use as potential antioxidant agent candidates.…”
    Get full text
    Article
  18. 118

    Latest Approved Therapies for Metastatic Melanoma: What Comes Next? by Farid Menaa

    Published 2013-01-01
    “…., sequence and timing of agent administration; drug selectivity; compatibility of combined therapies i.e., adoptive T cell or agents, i.e., MEK inhibitor trametinib, PD-1 and PDL-1 blockers). …”
    Get full text
    Article
  19. 119
  20. 120